@article{brahmer2012safety,
  title={Safety and activity of anti--PD-L1 antibody in patients with advanced cancer},
  author={Brahmer, Julie R and Tykodi, Scott S and Chow, Laura QM and Hwu, Wen-Jen and Topalian, Suzanne L and Hwu, Patrick and Drake, Charles G and Camacho, Luis H and Kauh, John and Odunsi, Kunle and others},
  journal={New England Journal of Medicine},
  volume={366},
  number={26},
  pages={2455--2465},
  year={2012},
  publisher={Mass Medical Soc}
}

@article{reck2016pembrolizumab,
  title={Pembrolizumab versus chemotherapy for PD-L1--positive non--small-cell lung cancer},
  author={Reck, Martin and Rodr{\'\i}guez-Abreu, Delvys and Robinson, Andrew G and Hui, Rina and Cs{\H{o}}szi, Tibor and F{\"u}l{\"o}p, Andrea and Gottfried, Maya and Peled, Nir and Tafreshi, Ali and Cuffe, Sinead and others},
  journal={New England Journal of Medicine},
  volume={375},
  number={19},
  pages={1823--1833},
  year={2016},
  publisher={Mass Medical Soc}
}

@article{iwai2002involvement,
  title={Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade},
  author={Iwai, Yoshiko and Ishida, Masayoshi and Tanaka, Yoshimasa and Okazaki, Taku and Honjo, Tasuku and Minato, Nagahiro},
  journal={Proceedings of the National Academy of Sciences},
  volume={99},
  number={19},
  pages={12293--12297},
  year={2002},
  publisher={National Acad Sciences}
}
